17DMAG along with PD184352, a mitogen protein kinase inhibitor, downregulated ERK1/2 and Bcl-xL levels and caused apoptosis in CML cells sensitive as well as resistant to imatinib [76]. The gene discussed is BCL2L1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.